4//SEC Filing
venBio Global Strategic Fund II L.P. 4
Accession 0001012975-20-000033
CIK 0001744659other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 8:58 AM ET
Size
11.7 KB
Accession
0001012975-20-000033
Insider Transaction Report
Form 4
venBio Global Strategic GP II, Ltd.
10% Owner
Transactions
- Sale
Common Stock
2020-01-13$20.23/sh−494,000$9,993,620→ 3,322,138 total(indirect: See footnote)
venBio Global Strategic Fund II L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-01-13$20.23/sh−494,000$9,993,620→ 3,322,138 total(indirect: See footnote)
Adelman Robert J
10% Owner
Transactions
- Sale
Common Stock
2020-01-13$20.23/sh−494,000$9,993,620→ 3,322,138 total(indirect: See footnote)
venBio Global Strategic GP II, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-01-13$20.23/sh−494,000$9,993,620→ 3,322,138 total(indirect: See footnote)
GOODMAN COREY S
10% Owner
Transactions
- Sale
Common Stock
2020-01-13$20.23/sh−494,000$9,993,620→ 3,322,138 total(indirect: See footnote)
Footnotes (1)
- [F1]These shares are held by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP II, Ltd. Each of venBio Global Strategic GP II, L.P., venBio Global Strategic GP II, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001634632
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 8:58 AM ET
- Size
- 11.7 KB